Company Filing History:
Years Active: 2025
Title: Hyeonho Jeon: Innovator in Pharmaceutical Chemistry
Introduction
Hyeonho Jeon is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target protein kinase-related diseases. His innovative work has the potential to impact the treatment of various cancers and degenerative diseases.
Latest Patents
Hyeonho Jeon holds a patent for a pyrrolopyridine derivative and its use in the prevention and treatment of protein kinase-related diseases. This invention is particularly noteworthy for its excellent inhibitory activity against various protein kinases, including LRRK2, DYRK1, and CLK1. The compound demonstrates a remarkable suppressive effect on the growth of triple-negative breast cancer cells. The pharmaceutical composition derived from this invention can be effectively used to treat or prevent protein kinase-related diseases, including cancers, degenerative brain diseases, and inflammatory diseases.
Career Highlights
Hyeonho Jeon is associated with Voronoi Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges through scientific discovery.
Collaborations
Hyeonho Jeon collaborates with talented colleagues, including Myungho Jung and Jungyeon Yun, to further enhance the impact of their research in the pharmaceutical field.
Conclusion
Hyeonho Jeon's contributions to pharmaceutical chemistry, particularly through his patented pyrrolopyridine derivative, highlight his role as an innovator in the treatment of serious health conditions. His work exemplifies the potential of scientific research to lead to significant advancements in medicine.